Safety and effectiveness of ramucirumab and docetaxel: a single-arm, prospective, multicenter, non-interventional, observational, post-marketing safety study of NSCLC in Japan

2021 ◽  
Author(s):  
Yucherng Chen ◽  
Soshi Nagaoka ◽  
Taeko Katayose ◽  
Nobuyuki Sekine
Keyword(s):  
Safety Study ◽  
Post Marketing

scholarly journals Su1835 – Vedolizumab Use is Not Associated with Increased Malignancy Incidence: Gemini Long-Term Safety Study Results and Post-Marketing Data

2019 ◽  
Vol 156 (6) ◽  
pp. S-628 ◽  
Author(s):  
Timothy Card ◽  
Ryan C. Ungaro ◽  
Fatima Bhayat ◽  
Aimee Blake ◽  
Gary Hantsbarger ◽  
...  
Keyword(s):  
Safety Study ◽  
Study Results ◽  
Post Marketing ◽  
Marketing Data

scholarly journals Safety of 300IR 5-Grass Tablet in Children with Grass Pollen-Induced Allergic Rhinoconjunctivitis: Results of an Observational, Post-Marketing Safety Study

2018 ◽  
Vol 141 (2) ◽  
pp. AB402 ◽  
Author(s):  
Michael Gertslauer ◽  
Zsolt Szepfalusi ◽  
David B.K. Golden ◽  
Agnès Viatte ◽  
Michel Melac ◽  
...  
Keyword(s):  
Grass Pollen ◽  
Allergic Rhinoconjunctivitis ◽  
Safety Study ◽  
Post Marketing
Sign in / Sign up

Export Citation Format

Share Document